HOME >> MEDICINE >> NEWS
International breast cancer prevention study launches in the United States and Canada

Boston-March 30, 2005 Today, a new clinical trial evaluating a novel approach to breast cancer prevention launched in the United States and Canada. Called the ExCel research study, this is the first North American clinical trial to evaluate the role of an aromatase inhibitor in the prevention of breast cancer.

Coordinated by the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG), the ExCel research study will examine the potential benefit of exemestane and its ability to prevent breast cancer in women who are at increased risk for the disease. Exemestane part of a class of drugs called aromatase inhibitors suppresses estrogen production, a key component in the development of some types of breast cancer. Exemestane could provide women with an alternative option to tamoxifen, the only drug FDA approved for prevention of breast cancer.

"Breast cancer is a major public health issue every 30 seconds somewhere in the world a woman is diagnosed with this disease," says Dr. Paul Goss, the ExCel research study chair.

"Thousands of women have already beat breast cancer thanks to recent research on aromatase inhibitors. As a result, we think this could be an effective approach to preventing it from developing in the first place."

The ExCel research study will follow more than 4,500 postmenopausal women from the U.S., Canada and Spain over a five year period. To be eligible, women must be 35 years of age or older and have an increased risk of developing breast cancer. Risk factors can include a woman's age, her family history of breast cancer, her age at first menstrual period and her age at first live birth.

Initial results of the trial could be available within four years and study investigators hope to see as much as a two-thirds reduction in the incidence of breast cancer among women in the treatment group.

Aromatase inhibitors are currently being used to treat breast cancer in wo
'"/>

Contact: Samantha Kaplan
samantha.kaplan@edelman.com
312-297-7439
Edelman Public Relations
30-Mar-2005


Page: 1 2 3 4

Related medicine news :

1. National Academies advisory: May 2 Symposium on International Science Policy
2. Awards & fellowships at the International & American Association for Dental Research General Session
3. Lectures, keynoters, symposia highlight International Dental Research meeting
4. Advances in Uterine Leiomyoma Research: 2nd NIH International Congress
5. International gathering of experts to share retinoblastoma breakthroughs
6. International trial of two microbicides begins
7. International gathering at UH examines top computer code
8. International trial finds benefits of breast MRI in women at high risk
9. International study provides culture-by-culture clues to family violence and abuse
10. St. Jude scientist wins International Society of Experimental Hematology award
11. International MRC trial finds a routine treatment for head injury may do more harm than good

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/4/2019)... ... December 04, 2019 , ... Now a patented ... from disruptions to cells and tissue and inflammation that leads to Jet Lag ... available in a dietary supplement product called Prepair™ . , Today, millions ...
(Date:12/4/2019)... ... December 04, 2019 , ... Healthcare ... Awards™, the only national awards dedicated to recognizing excellence in the areas of ... were presented in nine different categories during the GlobeSt Healthcare Conference today in ...
(Date:12/4/2019)... and CHAPEL HILL, N.C. (PRWEB) , ... December 04, 2019 , ... ... patients and their families easily find their way around the campuses of UNC Medical ... turn-by-turn navigation inside the two hospitals, parking garages, clinics and more. , The free ...
(Date:12/2/2019)... ... ... More than $400 million dollars are forfeited in FSA funds to the use-it-or-lose-it ... funds throughout the year, many more wait to the last-minute --- sometimes even right ... holders use -- not lose -- their funds this year, FSAstore.com is ...
(Date:12/2/2019)... (PRWEB) , ... December 02, 2019 , ... Interim ... a silver winner of the 2019 Workforce: Optimas Awards . Selected for its ... first and foremost to help combat the nation’s caregiver shortage. By 2025, the U.S. ...
Breaking Medicine News(10 mins):
(Date:12/2/2019)... (PRWEB) , ... December 02, 2019 , ... Today asensei, ... to offer a complete solution for digital fitness experience creators. , As more and ... upon which companies can differentiate their products and decrease time to market. This partnership ...
(Date:11/30/2019)... ... November 29, 2019 , ... ACC Medlink has been waiting more than two ... Amazon’s incredibly large purchase of these vehicles for their Prime delivery services. ... received word on vehicle availability and are expecting to have the new 2020 Mercedes ...
(Date:11/27/2019)... , ... November 27, 2019 , ... ... to help those suffering from extreme dry skin disorders. Urea is a ... grail ingredient provides intensive hydration to restore moisture balance for consumers with very ...
Breaking Medicine Technology:
Cached News: